FindTrial
Sign In

The Study On Enhanced Hypnotic Effect of Intravenous Propofol by Administration Of Lignocaine.

The Study on Enhanced Hypnotic Effect of Intravenous Propofol by Administration of Lignocaine - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078702
Enrollment
62
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection Lignocaine: 1.5mg/kg,Intravenous Control Intervention1: injection lignocaine: 2mg/kg, intravenous

Sponsors

Sri Devaraj Urs Academy of Higher Education and Research
Lead Sponsor
Emy Maria Eloor
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 AND 2

Exclusion criteria

Exclusion criteria: 1.SEVERE CARDIOVASCULAR DISEASES 2.EMERGENCY SURGERIES 3.PATIENT UNWILLING TO PARTICIPATE IN STUDY 4.ANY ALLERGIC REACTION TO THE DRUG

Design outcomes

Primary

MeasureTime frame
induction time dose of the induction medicationTimepoint: After 5 minutes of injection of drug—

Secondary

MeasureTime frame
total dose of propofol used for inductionTimepoint: at the end of induction—

Countries

India

Contacts

Public ContactEMY MARIA ELOOR

Sri Devaraj Urs Academy of Higher Education & Research

drdini2233@gmail.com9880463098

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026